title: Severe hypertriglyceridaemia during treatment with capecitabine.
authors.forename: L
authors.initials: L
authors.lastname: Javot
authors.forename: D
authors.initials: D
authors.lastname: Spaëth
authors.forename: J
authors.initials: J
authors.lastname: Scala-Bertola
authors.forename: N
authors.initials: N
authors.lastname: Gambier
authors.forename: N
authors.initials: N
authors.lastname: Petitpain
authors.forename: P
authors.initials: P
authors.lastname: Gillet
mesh_terms: D000964:Antimetabolites, Antineoplastic / Q000009:adverse effects*; D000069287:Capecitabine; D003841:Deoxycytidine / Q000009:adverse effects / Q000031:analogs & derivatives*; D005260:Female; D005472:Fluorouracil / Q000009:adverse effects / Q000031:analogs & derivatives*; D006801:Humans; D015228:Hypertriglyceridemia / Q000139:chemically induced*; D008875:Middle Aged
chemical_list: D000964:Antimetabolites, Antineoplastic; D003841:Deoxycytidine; D000069287:Capecitabine; D005472:Fluorouracil